Wells Fargo
JANX icon

Wells Fargo’s Janux Therapeutics JANX Stock Holding History

Wells Fargo’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Buy
48,726
+23,846
+96% +$345K ﹤0.01% 4307
2026
Q1 		$346K Sell
24,880
-23,039
-48% -$316K ﹤0.01% 4352
2025
Q4 		$661K Buy
47,919
+19,401
+68% +$456K ﹤0.01% 4269
2025
Q3 		$697K Buy
28,518
+4,835
+20% +$118K ﹤0.01% 4067
2025
Q2 		$547K Buy
23,683
+8,338
+54% +$220K ﹤0.01% 4078
2025
Q1 		$414K Buy
15,345
+2,094
+16% +$78.9K ﹤0.01% 4228
2024
Q4 		$709K Buy
13,251
+4,585
+53% +$243K ﹤0.01% 3948
2024
Q3 		$394K Sell
8,666
-341
-4% -$14.8K ﹤0.01% 4146
2024
Q2 		$377K Buy
9,007
+2,907
+48% +$136K ﹤0.01% 4089
2024
Q1 		$230K Buy
6,100
+812
+15% +$17.7K ﹤0.01% 4386
2023
Q4 		$56.7K Buy
5,288
+1,023
+24% +$8.85K ﹤0.01% 5224
2023
Q3 		$43K Sell
4,265
-2,368
-36% -$27.3K ﹤0.01% 5258
2023
Q2 		$78.7K Buy
6,633
+3,548
+115% +$47.4K ﹤0.01% 5178
2023
Q1 		$37.3K Buy
+3,085
New +$51.3K ﹤0.01% 5322
2022
Q4 		– Sell
-45
Closed -$1K – 7594
2022
Q3 		$1K Sell
45
-29,595
-100% -$395K ﹤0.01% 6370
2022
Q2 		$362K Buy
29,640
+24,898
+525% +$295K ﹤0.01% 3941
2022
Q1 		$68K Sell
4,742
-3,481
-42% -$57K ﹤0.01% 5512
2021
Q4 		$163K Buy
8,223
+8,149
+11,012% +$171K ﹤0.01% 5381
2021
Q3 		$2K Buy
+74
New +$2.13K ﹤0.01% 6574

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Wells Fargo's JANX Position: Q2 2026 in Review

Wells Fargo increased its Janux Therapeutics (JANX) stake by 96% in Q2 2026, buying an estimated $345K and bringing the position to 48,726 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #4307.

Wells Fargo first reported a position in JANX in Q3 2021 and has held it in 19 quarters since. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Wells Fargo held 48,726 shares of Janux Therapeutics worth $748K as of Q2 2026.
  • Wells Fargo bought 23,846 Janux Therapeutics shares in Q2 2026, an estimated $345K.
  • Janux Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4307 holding.
  • Wells Fargo first reported a position in Janux Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.